Strategies of human corneal endothelial tissue regeneration

Regenerative Medicine

Volumn 8, Issue 2, 2013, Pages 183-195

  Sabater, Alfonso L ^a   Guarnieri, Adriano ^a   Espana, Edgar M ^b   Li, Wei ^c   Prósper, Felipe ^a   Moreno Montañés, Javier ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c XIAMEN UNIVERSITY   (China)

Author keywords

corneal endothelial dysfunction; corneal endothelial regeneration; corneal transplantation; tissue engineering

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; BETA CATENIN; COLLAGEN TYPE 4; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBRONECTIN; NERVE CELL ADHESION MOLECULE; PROTEIN P120; PROTEIN P190; UVOMORULIN; VASCULAR ENDOTHELIAL CADHERIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CELL DENSITY; CELL EXPANSION; CELL JUNCTION; CELL PROLIFERATION; CONGENITAL CORNEA DYSTROPHY; CONTROLLED STUDY; CORNEA DISEASE; CORNEA ENDOTHELIUM; CORNEA TRANSPLANTATION; CULTURE MEDIUM; DEEP LAMELLAR ENDOTHELIAL KERATOPLASTY; DESCEMET STRIPPING ENDOTHELIAL KERATOPLASTY; DONOR; ENDOTHELIAL DYSFUNCTION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; NONHUMAN; PENETRATING KERATOPLASTY; PHENOTYPE; PRIORITY JOURNAL; RABBIT; REVIEW; SPECULAR MICROSCOPY; TISSUE ENGINEERING; TISSUE REGENERATION; WOUND HEALING;

ANIMALS; ENDOTHELIAL CELLS; ENDOTHELIUM, CORNEAL; HUMANS; REGENERATION; REGENERATIVE MEDICINE; TISSUE ENGINEERING; TISSUE PRESERVATION;

EID: 84874827962     PISSN: 17460751     EISSN: 1746076X     Source Type: Journal    
DOI: 10.2217/rme.13.11     Document Type: Review

References (53)

1. Hollingsworth J, Perez-Gomez I, Mutalib HA, Efron N. A population study of the normal cornea using an in vivo, slit-scanning confocal microscope. Optom. Vis. Sci. 78(10), 706-711 (2001).
2. Joyce NC. Proliferative capacity of the corneal endothelium. Prog. Retin. Eye Res. 22(3), 359-389 (2003).
3. Melles GR, Eggink FA, Lander F et al. A surgical technique for posterior lamellar keratoplasty. Cornea 17(6), 618-626 (1998).
4. Melles GRJ, Wijdh RHJ, Nieuwendaal CP. A technique to excise the descemet membrane from a recipient cornea (descemetorhexis). Cornea 23(3), 286-288 (2004).
5. Gorovoy MS. Descemet-stripping automated endothelial keratoplasty. Cornea 25(8), 886-889 (2006).
6. Bahar I, Kaiserman I, McAllum P, Slomovic A, Rootman D. Comparison of posterior lamellar keratoplasty techniques to penetrating keratoplasty. Ophthalmology 115(9), 1525-1533 (2008).
7. Price FW, Price MO. Does endothelial cell survival differ between DSEK and standard PK? Ophthalmology 116(3), 367-368 (2009).
8. Balachandran C, Ham L, Verschoor CA, Ong TS, van der Wees J, Melles GRJ. Spontaneous corneal clearance despite graft detachment in Descemet membrane endothelial keratoplasty. Am. J. Ophthalmol. 148(2), 227-234.e1 (2009).
9. Price FW, Price MO. Spontaneous corneal clearance despite graft detachment after descemet membrane endothelial keratoplasty. Am. J. Ophthalmol. 149(1), 173-174, author reply 174-175 (2010).
10. Zafirakis P, Kymionis GD, Grentzelos MA, Livir-Rallatos G. Corneal graft detachment without corneal edema after descemet stripping automated endothelial keratoplasty. Cornea 29(4), 456-458 (2010).
11. Shah RD, Randleman JB, Grossniklaus HE. Spontaneous corneal clearing after Descemet's stripping without endothelial replacement. Ophthalmology 119(2), 256-260 (2012).
12. Dirisamer M, Yeh R-Y, van Dijk K, Ham L, Dapena I, Melles GRJ. Recipient endothelium may relate to corneal clearance in descemet membrane endothelial transfer. Am. J. Ophthalmol. 154(2), 290-296.e1 (2012).
13. Whitcher JP, Srinivasan M, Upadhyay MP. Corneal blindness: a global perspective. Bull. World Health Organ. 79(3), 214-221 (2001).
14. Christensen K, Doblhammer G, Rau R, Vaupel JW. Ageing populations: the challenges ahead. Lancet 374(9696), 1196-1208 (2009).
15. Ruberti JW, Zieske JD. Prelude to corneal tissue engineering -gaining control of collagen organization. Prog. Retin. Eye Res. 27(5), 549-577 (2008).
16. Senoo T, Joyce NC. Cell cycle kinetics in corneal endothelium from old and young donors. Invest. Ophthalmol. Vis. Sci. 41(3), 660-667 (2000).
17. Joyce NC, Zhu CC. Human corneal endothelial cell proliferation: potential for use in regenerative medicine. Cornea 23(Suppl. 8), S8-S19 (2004).
18. Bednarz J, Rodokanaki-von Schrenck A, Engelmann K. Different characteristics of endothelial cells from central and peripheral human cornea in primary culture and after subculture. In vitro Cell. Dev. Biol. Anim. 34(2), 149-153 (1998).
19. Mimura T, Joyce NC. Replication competence and senescence in central and peripheral human corneal endothelium. Invest. Ophthalmol. Vis. Sci. 47(4), 1387-1396 (2006).
20. Ishino Y, Sano Y, Nakamura T et al. Amniotic membrane as a carrier for cultivated human corneal endothelial cell transplantation. Invest. Ophthalmol. Vis. Sci. 45(3), 800-806 (2004).
21. Li W, Sabater AL, Chen YT et al. A novel method of isolation, preservation, and expansion of human corneal endothelial cells. Invest. Ophthalmol. Vis. Sci. 48(2), 614-620 (2007).
22. Zhu C, Joyce NC. Proliferative response of corneal endothelial cells from young and older donors. Invest. Ophthalmol. Vis. Sci. 45(6), 1743-1751 (2004).
23. Engelmann K, Böhnke M, Friedl P. Isolation and long-term cultivation of human corneal endothelial cells. Invest. Ophthalmol. Vis. Sci. 29(11), 1656-1662 (1988).
24. Patel SV, Bachman LA, Hann CR, Bahler CK, Fautsch MP. Human corneal endothelial cell transplantation in a human ex vivo model. Invest. Ophthalmol. Vis. Sci. 50(5), 2123-2131 (2009).
25. Yokoo S, Yamagami S, Yanagi Y et al. Human corneal endothelial cell precursors isolated by sphere-forming assay. Invest. Ophthalmol. Vis. Sci. 46(5), 1626-1631 (2005).
26. Hitani K, Yokoo S, Honda N, Usui T, Yamagami S, Amano S. Transplantation of a sheet of human corneal endothelial cell in a rabbit model. Mol. Vis. 14, 1-9 (2008).
27. Ide T, Nishida K, Yamato M et al. Structural characterization of bioengineered human corneal endothelial cell sheets fabricated on temperature-responsive culture dishes. Biomaterials 27(4), 607-614 (2006).
28. Mimura T, Yamagami S, Yokoo S et al. Cultured human corneal endothelial cell transplantation with a collagen sheet in a rabbit model. Invest. Ophthalmol. Vis. Sci. 45(9), 2992-2997 (2004).
29. Mimura T, Yokoo S, Araie M, Amano S, Yamagami S. Treatment of rabbit bullous keratopathy with precursors derived from cultured human corneal endothelium. Invest. Ophthalmol. Vis. Sci. 46(10), 3637-3644 (2005).
30. Stenn KS, Link R, Moellmann G, Madri J, Kuklinska E. Dispase, a neutral protease from Bacillus polymyxa, is a powerful fibronectinase and type IV collagenase. J. Invest. Dermatol. 93(2), 287-290 (1989).
31. Chu W. The past twenty-five years in eye banking. Cornea 19(5), 754-765 (2000).
32. Böhnke M, Eggli P, Engelmann K. Transplantation of cultured adult human or porcine corneal endothelial cells onto human recipients in vitro. Part II: evaluation in the scanning electron microscope. Cornea 18(2), 207-213 (1999).
33. Lee JG, Kay EP. FGF-2-mediated signal transduction during endothelial mesenchymal transformation in corneal endothelial cells. Exp. Eye Res. 83(6), 1309-1316 (2006).
34. Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J. Clin. Invest. 112(12), 1776-1784 (2003).
35. Masszi A, Fan L, Rosivall L et al. Integrity of cell-cell contacts is a critical regulator of TGF-beta 1-induced epithelial-to-myofibroblast transition: role for beta-catenin. Am. J. Pathol. 165(6), 1955-1967 (2004).
36. Kent KD, Bomser JA. Bovine pituitary extract provides remarkable protection against oxidative stress in human prostate epithelial cells. In vitro Cell. Dev. Biol. Anim. 39(8-9), 388-394 (2003).
37. Shima N, Kimoto M, Yamaguchi M, Yamagami S. Increased proliferation and replicative lifespan of isolated human corneal endothelial cells with l-ascorbic acid 2-phosphate. Invest. Ophthalmol. Vis. Sci. 52(12), 8711-8717 (2011).
38. Blake DA, Yu H, Young DL, Caldwell DR. Matrix stimulates the proliferation of human corneal endothelial cells in culture. Invest. Ophthalmol. Vis. Sci. 38(6), 1119-1129 (1997).
39. Howell DN, Burchette JL, Paolini JF, Geier SS, Fuller JA, Sanfilippo F. Characterization of a novel human corneal endothelial antigen. Invest. Ophthalmol. Vis. Sci. 32(9), 2473-2482 (1991).
40. Engelmann K, Bednarz J, Schäfer HJ, Friedl P. Isolation and characterization of a mouse monoclonal antibody against human corneal endothelial cells. Exp. Eye Res. 73(1), 9-16 (2001).
41. Böhnke M, Vogelberg K, Engelmann K. Detection of neurone-specific enolase in long-term cultures of human corneal endothelium. Graefes Arch. Clin. Exp. Ophthalmol. 236(7), 522-526 (1998).
42. Petroll WM, Hsu JK, Bean J, Cavanagh HD, Jester JV. The spatial organization of apical junctional complex-associated proteins in feline and human corneal endothelium. Curr. Eye Res. 18(1), 10-19 (1999).
43. Zhu YT, Hayashida Y, Kheirkhah A, He H, Chen SY, Tseng SC. Characterization and comparison of intercellular adherent junctions expressed by human corneal endothelial cells in vivo and in vitro. Invest. Ophthalmol. Vis. Sci. 49(9), 3879-3886 (2008).
44. Huang B, Blanco G, Mercer RW, Fleming T, Pepose JS. Human corneal endothelial cell expression of Na+, K+-adenosine triphosphatase isoforms. Arch. Ophthalmol. 121(6), 840-845 (2003).
45. Mimura T, Yamagami S, Usui T, Seiichi Honda N, Amano S. Necessary prone position time for human corneal endothelial precursor transplantation in a rabbit endothelial deficiency model. Curr. Eye Res. 32(7-8), 617-623 (2007).
46. Mimura T, Yamagami S, Usui T et al. Long-term outcome of iron-endocytosing cultured corneal endothelial cell transplantation with magnetic attraction. Exp. Eye Res. 80(2), 149-157 (2005).
47. Okumura N, Koizumi N, Ueno M et al. The new therapeutic concept of using a rho kinase inhibitor for the treatment of corneal endothelial dysfunction. Cornea 30(Suppl. 1), S54-S59 (2011).
48. Okumura N, Koizumi N, Ueno M et al. Enhancement of corneal endothelium wound healing by Rho-associated kinase (ROCK) inhibitor eye drops. Br. J. Ophthalmol. 95(7), 1006-1009 (2011).
49. Bednarz J, Doubilei V, Wollnik PC, Engelmann K. Effect of three different media on serum free culture of donor corneas and isolated human corneal endothelial cells. Br. J. Ophthalmol. 85(12), 1416-1420 (2001).
50. Jäckel T, Knels L, Valtink M, Funk RHW, Engelmann K. Serum-free corneal organ culture medium (SFM) but not conventional minimal essential organ culture medium (MEM) protects human corneal endothelial cells from apoptotic and necrotic cell death. Br. J. Ophthalmol. 95(1), 123-130 (2011).
51. Okumura N, Ueno M, Koizumi N et al. Enhancement on primate corneal endothelial cell survival in vitro by a ROCK inhibitor. Invest. Ophthalmol. Vis. Sci. 50(8), 3680-3687 (2009).
52. Koizumi N, Okumura N, Kinoshita S. Development of new therapeutic modalities for corneal endothelial disease focused on the proliferation of corneal endothelial cells using animal models. Exp. Eye Res. 95(1), 60-67 (2012).
53. Hatou S, Yoshida S, Higa K et al. Functional corneal endothelium derived from corneal stroma stem cells of neural crest origin by retinoic acid and Wnt/b-catenin signaling. Stem Cells Dev. 22(5), 828-839 (2013).